ADC Therapeutics SA
NYSE:ADCT
ADC Therapeutics SA
Accumulated Depreciation
ADC Therapeutics SA
Accumulated Depreciation Peer Comparison
Competitive Accumulated Depreciation Analysis
Latest Figures & CAGR of Competitors
Company | Accumulated Depreciation | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ADC Therapeutics SA
NYSE:ADCT
|
Accumulated Depreciation
-$4.3m
|
CAGR 3-Years
-2%
|
CAGR 5-Years
-34%
|
CAGR 10-Years
N/A
|
|
AC Immune SA
NASDAQ:ACIU
|
Accumulated Depreciation
-CHf11m
|
CAGR 3-Years
-24%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
CRISPR Therapeutics AG
NASDAQ:CRSP
|
Accumulated Depreciation
-$53.4m
|
CAGR 3-Years
-36%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
Basilea Pharmaceutica AG
SIX:BSLN
|
Accumulated Depreciation
-CHf10.9m
|
CAGR 3-Years
23%
|
CAGR 5-Years
22%
|
CAGR 10-Years
N/A
|
|
Idorsia Ltd
SIX:IDIA
|
Accumulated Depreciation
-CHf96.9m
|
CAGR 3-Years
-27%
|
CAGR 5-Years
-58%
|
CAGR 10-Years
N/A
|
|
Kuros Biosciences AG
SIX:KURN
|
Accumulated Depreciation
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is ADC Therapeutics SA's Accumulated Depreciation?
Accumulated Depreciation
-4.3m
USD
Based on the financial report for Dec 31, 2023, ADC Therapeutics SA's Accumulated Depreciation amounts to -4.3m USD.
What is ADC Therapeutics SA's Accumulated Depreciation growth rate?
Accumulated Depreciation CAGR 5Y
-34%
Over the last year, the Accumulated Depreciation growth was -30%. The average annual Accumulated Depreciation growth rates for ADC Therapeutics SA have been -2% over the past three years , -34% over the past five years .